Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS?

Valeria Santini, Jennifer Schemenau, Alessandro Levis, Enrico Balleari, Rosa Sapena, Lionel Adès, Agnès Guerci, Odile Beyne-Rauzy, Marie Pierre Gourin, Stephane Cheze, Aspasia Stamatoullas, Alessandro Sanna, Daniela Gioia, Gianni Cametti, Dario Ferrero, Emmanuel Raffoux, Christian Rose, Antonella Poloni, Thomas Prebet, Laurence LegrosShanti Natarajan-Amé, Pierre Fenaux, Ulrich Germing, François Dreyfus, Sophie Park

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)2286-2288
Number of pages3
JournalBlood
Volume122
Issue number13
DOIs
Publication statusPublished - Sep 26 2013

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Santini, V., Schemenau, J., Levis, A., Balleari, E., Sapena, R., Adès, L., Guerci, A., Beyne-Rauzy, O., Gourin, M. P., Cheze, S., Stamatoullas, A., Sanna, A., Gioia, D., Cametti, G., Ferrero, D., Raffoux, E., Rose, C., Poloni, A., Prebet, T., ... Park, S. (2013). Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS? Blood, 122(13), 2286-2288. https://doi.org/10.1182/blood-2013-07-512442